Kjeken Ingvild, Bordvik Daniel Huseby, Osteras Nina, Haugen Ida K, Aasness Fjeldstad Kristine, Skaalvik Ingrid, Kloppenburg Margreet, Kroon Féline P B, Tveter Anne Therese, Smedslund Geir
Health Services Research and Innovation Unit, Diakonhjemmet Hospital, Oslo, Norway
Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
RMD Open. 2025 Jan 9;11(1):e004963. doi: 10.1136/rmdopen-2024-004963.
We aimed to update the 2018 systematic literature review on the efficacy and safety of treatments for hand osteoarthritis (OA), which was based on 126 studies.
We performed a systematic literature search on randomised controlled trials from June 2017 up to 31 December 2023. Risk of bias was assessed using the RoB2 tool. Meta-analyses of previous and new studies regarding the efficacy for pain, function, grip strength and OMERACT/OARSI responders were performed. Certainty of evidence was judged using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) tool.
Sixty-five new studies were included. For non-pharmacological interventions, there was low-certainty evidence for a small long-term effect of hand exercises and a moderate long-term effect of thumb orthoses for pain, and moderate-certainty evidence that assistive devices had a moderate long-term effect on function. Concerning pharmacological interventions, there was low-certainty evidence for a moderate short-term effect of oral non-steroidal anti-inflammatory drugs (NSAIDs) on pain, high- and moderate-certainty evidence for a small short-term effect of topical NSAIDs and oral glucocorticoids on function, respectively, and low-certainty evidence that oral glucocorticoids had a small short-term effect on function. Further, there was low-certainty evidence that methotrexate had a small long-term effect on pain. The heterogeneity of studies did not allow for any meta-analyses on surgery.
The results largely support current treatment recommendations. However, there is a lack of interventions that efficiently improve grip strength, and the evidence for most current treatments is still limited. To better understand action mechanism of different treatments, future trials should include hand OA subtyping and be powered for subgroup analyses.
我们旨在更新2018年关于手部骨关节炎(OA)治疗的疗效和安全性的系统文献综述,该综述基于126项研究。
我们对2017年6月至2023年12月31日期间的随机对照试验进行了系统文献检索。使用RoB2工具评估偏倚风险。对既往和新研究中关于疼痛、功能、握力和OMERACT/OARSI反应者疗效的进行荟萃分析。使用GRADE(推荐分级评估、制定和评价)工具判断证据的确定性。
纳入了65项新研究。对于非药物干预,有低确定性证据表明手部锻炼有小的长期疼痛缓解作用,拇指矫形器有中度长期疼痛缓解作用,有中度确定性证据表明辅助装置对功能有中度长期影响。关于药物干预,有低确定性证据表明口服非甾体抗炎药(NSAIDs)对疼痛有中度短期作用,有高确定性和中度确定性证据表明局部NSAIDs和口服糖皮质激素分别对功能有小的短期作用,有低确定性证据表明口服糖皮质激素对功能有小的短期作用。此外,有低确定性证据表明甲氨蝶呤对疼痛有小的长期作用。研究的异质性使得无法对手术进行任何荟萃分析。
结果在很大程度上支持当前的治疗建议。然而,缺乏能有效提高握力的干预措施,且目前大多数治疗方法的证据仍然有限。为了更好地理解不同治疗方法的作用机制,未来的试验应包括手部OA亚型分类,并具备亚组分析的能力。